Stuart Poulton
EVP, Chief Development Officer · 5 filings · Latest: Jul 28, 2026
Karyopharm Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KPTI | Stuart Poulton | EVP, Chief Development Officer | Jul 28, 2026 | Sale | $7.10 | 189 | $1.3K | 94,632 | |
KPTI | Stuart Poulton | EVP, Chief Development Officer | May 14, 2026 | Sale | $9.50 | 403 | $3.8K | 94,821 | |
KPTI | Stuart Poulton | EVP, Chief Development Officer | Mar 2, 2026 | Sale | $9.41 | 5,101 | $48.0K | 94,328 | |
KPTI | Stuart Poulton | EVP, Chief Development Officer | Feb 17, 2026 | Sale | $8.63 | 378 | $3.3K | 99,429 |